These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12870449)

  • 1. Testosterone cream available at CPS; gel approved by FDA.
    James JS
    AIDS Treat News; 2000 Mar; (339):4. PubMed ID: 12870449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New testosterone therapy OK'd.
    Leibovich M
    Posit Living; 2000 Jul; 9(6):21. PubMed ID: 12492015
    [No Abstract]   [Full Text] [Related]  

  • 3. Home test system for HIV approved by FDA.
    J Psychosoc Nurs Ment Health Serv; 1996 Aug; 34(8):9. PubMed ID: 8856597
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA notifications. Generic emtricitabine is approved by the FDA.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19222147
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA notifications. FDA approved 3 generic formulations of stavudine.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19219951
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA notifications. Generic lopinavir/ritonavir approved by FDA.
    AIDS Alert; 2009 May; 24(5):59. PubMed ID: 19452652
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA notifications. NRTI Emtriva receives FDA approval.
    AIDS Alert; 2003 Oct; 18(10):131-2. PubMed ID: 14686301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA approves two combination pills, Epzicom and Truvada; comment on commercial race to once-a-day nucleosides.
    James JS
    AIDS Treat News; 2004 Jul; (403):6. PubMed ID: 15386855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA notifications. FDA approved pediatric efficacy supplement for Retrovir syrup.
    AIDS Alert; 2008 Nov; 23(11):128. PubMed ID: 19043870
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. Generic lamivudine tentatively approved.
    AIDS Alert; 2008 Mar; 23(3):33. PubMed ID: 18661640
    [No Abstract]   [Full Text] [Related]  

  • 11. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA notifications. Alternative dosing regimen for atazanavir is approved.
    AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA notifications. Two tenofovir containing products are approved.
    AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16795142
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic monoclonal antibodies: trends in development and approval in the US.
    Reichert JM
    Curr Opin Mol Ther; 2002 Apr; 4(2):110-8. PubMed ID: 12044031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV therapy update.
    Proj Inf Perspect; 2002 Mar; (34):4-6. PubMed ID: 12038301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA notifications. Reyataz is approved for HIV treatment.
    AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone cream and gel available; prices vary greatly.
    Tobias T; James JS
    AIDS Treat News; 1998 Nov; (No 307):1-3. PubMed ID: 11366124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA notifications. Lamivudine/zidovudine combination approved for pediatric use.
    AIDS Alert; 2009 Sep; 24(9):105. PubMed ID: 19938311
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA notifications. Efavirenz 100 mg scored tablets approved for pediatric treatment.
    AIDS Alert; 2009 Mar; 24(3):34-5. PubMed ID: 19445002
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA notifications. Generic zidovudine oral solution approved.
    AIDS Alert; 2008 Aug; 23(8):90. PubMed ID: 18724489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.